These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 7679905

  • 1. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid.
    Blennow K, Wallin A, Gottfries CG, Månsson JE, Svennerholm L.
    J Neural Transm Park Dis Dement Sect; 1993; 5(1):5-15. PubMed ID: 7679905
    [Abstract] [Full Text] [Related]

  • 2. Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age.
    Blennow K, Wallin A, Gottfries CG, Karlsson I, Månsson JE, Skoog I, Wikkelsö C, Svennerholm L.
    Eur Neuropsychopharmacol; 1993 Mar; 3(1):55-61. PubMed ID: 7682460
    [Abstract] [Full Text] [Related]

  • 3. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
    Sjöström R, Ekstedt J, Anggård E.
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
    [Abstract] [Full Text] [Related]

  • 4. CSF concentration gradients of monoamine metabolites in patients with hydrocephalus.
    Malm J, Kristensen B, Ekstedt J, Wester P.
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1026-33. PubMed ID: 7522267
    [Abstract] [Full Text] [Related]

  • 5. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK, Nordin C, Jönsson EG, Engberg G, Linderholm KR, Erhardt S.
    J Psychiatr Res; 2007 Sep; 41(1-2):144-51. PubMed ID: 16434056
    [Abstract] [Full Text] [Related]

  • 6. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Hjärpe J, Söderman E, Andreou D, Sedvall GC, Agartz I, Jönsson EG.
    Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
    [Abstract] [Full Text] [Related]

  • 7. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.
    Blennow K, Wallin A, Gottfries CG, Lekman A, Karlsson I, Skoog I, Svennerholm L.
    Neurobiol Aging; 1992 May; 13(1):107-13. PubMed ID: 1371850
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers.
    Alfredsson G, Wiesel FA, Tylec A.
    Biol Psychiatry; 1988 Apr 01; 23(7):689-97. PubMed ID: 2453224
    [Abstract] [Full Text] [Related]

  • 10. Gradients of CSF monoamine metabolites: a comparison between male and female volunteers.
    Nordin C, Eklundh T, Fernström V, Swedin A, Zachau AC.
    J Psychiatr Res; 1995 Apr 01; 29(2):133-40. PubMed ID: 7545235
    [Abstract] [Full Text] [Related]

  • 11. CSF monoamine metabolites in patients and controls: support for a bimodal distribution in major affective disorders.
    Westenberg HG, Verhoeven WM.
    Acta Psychiatr Scand; 1988 Nov 01; 78(5):541-9. PubMed ID: 2466394
    [Abstract] [Full Text] [Related]

  • 12. Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient.
    Janssens J, Atmosoerodjo SD, Vermeiren Y, Absalom AR, den Daas I, De Deyn PP.
    Neurochem Int; 2019 Sep 01; 128():154-162. PubMed ID: 31034914
    [Abstract] [Full Text] [Related]

  • 13. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K.
    No To Shinkei; 1982 Nov 01; 34(11):1099-106. PubMed ID: 6186264
    [Abstract] [Full Text] [Related]

  • 14. Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.
    Vaughn DM, Smyth GB, Whitmer WL, Satjawatcharaphong C.
    Vet Res Commun; 1989 Nov 01; 13(3):237-49. PubMed ID: 2476887
    [Abstract] [Full Text] [Related]

  • 15. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
    von Holst H, Lindquist C, Sedvall G.
    Acta Neurochir (Wien); 1985 Nov 01; 77(3-4):146-51. PubMed ID: 2416192
    [Abstract] [Full Text] [Related]

  • 16. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
    Eriksson E, Alling C, Andersch B, Andersson K, Berggren U.
    Neuropsychopharmacology; 1994 Nov 01; 11(3):201-13. PubMed ID: 7532413
    [Abstract] [Full Text] [Related]

  • 17. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
    Tang HZ, Lu XF, Wang KJ, Ou YS, Huang YQ.
    Chin Med J (Engl); 1989 Jan 01; 102(1):18-23. PubMed ID: 2475306
    [Abstract] [Full Text] [Related]

  • 18. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
    Eklundh T, Eriksson M, Sjöberg S, Nordin C.
    J Psychiatr Res; 1996 Jan 01; 30(3):201-8. PubMed ID: 8884658
    [Abstract] [Full Text] [Related]

  • 19. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A, García JC, Fernández R, Fernández Cartaya L.
    Bol Estud Med Biol; 1993 Jan 01; 41(1-4):13-9. PubMed ID: 7521168
    [Abstract] [Full Text] [Related]

  • 20. Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease.
    Sjögren M, Minthon L, Passant U, Blennow K, Wallin A.
    Neurobiol Aging; 1998 Jan 01; 19(5):379-84. PubMed ID: 9880039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.